HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME: Take the course for this article: Volume 67, Number 12, December 26, 2006 Data Supplement All Versions of this Article: 01.wnl.0000233888.18228.19v1 67/12/2154    most recent Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MacGregor, E. A. Articles by Hackshaw, A. Search for Related Content PubMed PubMed Citation Articles by MacGregor, E. A. Articles by Hackshaw, A. Related Collections Migraine Endocrine All epidemiology Incidence studies

Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen

From the City of London Migraine Clinic (E.A.M., A.F.), Departments of Gynaecology and Sexual Health (E.A.M.), St Bartholomew's Hospital, and Cancer Research UK and University College London Cancer Trials Centre (A.H.), London, and Unipath Limited (J.E.), Priory Park, Bedford, Unilever Research (L.A.), Colworth House, Sharnbrook, UK.

Address correspondence and reprint requests to Dr MacGregor, City of London Migraine Clinic, 22 Charterhouse Square, London, EC1M 6DX, UK; e-mail: anne.macgregor{at}bartsandthelondon.nhs.uk

Objective: To investigate the association between urinary hormone levels and migraine, with particular reference to rising and falling levels of estrogen across the menstrual cycle in women with menstrual and menstrually related migraine.

Methods: Women with regular menstrual cycles, who were not using hormonal contraception or treatments and who experienced between one and four migraine attacks per month, one of which regularly occurred on or between days 1 ± 2 of menstruation, were studied for three cycles. Women used a fertility monitor to identify ovulation, conducting a test each day as requested by the monitor, using a sample of early morning urine. Urine samples were collected daily for assay of estrone-3-glucuronide, pregnanediol 3-glucuronide, follicle-stimulating hormone, and luteinizing hormone. All women kept a daily migraine diary and continued their usual treatment for migraine.

Results: Of 40 women recruited, data from 38 women were available for analysis. Compared with the expected number of attacks, there was a significantly higher number of migraine attacks during the late luteal/early follicular phase of falling estrogen and lower number of attacks during rising phases of estrogen.

Conclusion: These findings confirm a relationship between migraine and changing levels of estrogen, supporting the hypothesis of perimenstrual but not postovulatory estrogen "withdrawal" migraine. In addition, rising levels of estrogen appear to offer some protection against migraine.

See also page 2159

This article was previously published in electronic format as an Expedited E-Pub on September 13, 2006, at www.neurology.org

Supported by a grant from Unipath Limited.

Disclosure: E.A.M. has received consulting fees from Unipath Limited. E.A.M. and A.F. have received funding from Unipath to attend an international meeting. The City of London Migraine Clinic has received research funds from Unipath Limited. Clearblue Easy Fertility Monitors were supplied by Unipath Limited.

Received January 13, 2006. Accepted in final form April 27, 2006.

This article has been cited by other articles:

				V. M. Miller and S. P. Duckles Vascular Actions of Estrogens: Functional Implications Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241. [Abstract] [Full Text] [PDF]

				T. Pringsheim, W. J. Davenport, and D. Dodick Acute treatment and prevention of menstrually related migraine headache: Evidence-based review Neurology, April 22, 2008; 70(17): 1555 - 1563. [Abstract] [Full Text] [PDF]

				T. Lahm, K. M. Patel, P. R. Crisostomo, T. A. Markel, M. Wang, C. Herring, and D. R. Meldrum Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E865 - E871. [Abstract] [Full Text] [PDF]

				Menstrual Migraine: The Estrogen Paradox Journal Watch Neurology, March 13, 2007; 2007(313): 2 - 2. [Full Text]

				E. A. MacGregor, A. Frith, J. Ellis, L. Aspinall, and A. Hackshaw Prevention of menstrual attacks of migraine: A double-blind placebo-controlled crossover study Neurology, December 26, 2006; 67(12): 2159 - 2163. [Abstract] [Full Text] [PDF]